Acacia research corp (ACTG)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

58,678

57,359

66,861

63,487

73,285

128,809

109,562

100,150

150,289

136,604

101,081

63,220

54,321

127,540

116,016

139,772

145,329

135,223

157,775

119,084

101,548

134,466

154,257

146,040

133,403

126,685

118,303

148,909

193,161

221,804

264,151

296,866

315,498

314,733

310,663

299,415

102,515

Debt Securities, Trading

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trading Securities, Equity

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trading securities - debt

88,963

93,843

86,390

90,482

93,756

33,642

30,837

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trading securities - equity

10,470

17,140

16,080

10,934

831

3,012

3,011

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

11,512

-

-

-

10,725

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

0

0

11,515

-

14,041

14,036

11,523

-

10,721

10,718

10,718

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

34,694

29,359

-

57,487

55,052

90,927

19,443

30,326

32,243

-

0

0

37,090

53,289

58,558

72,459

74,798

95,590

130,017

166,998

171,216

134,287

89,475

146,647

132,496

134,185

6,597

6,514

-

0

Accounts receivable

621

511

1,799

15,308

23,964

32,884

10,572

5,629

4,754

153

300

14,245

7,781

26,750

53,700

4,325

25,175

33,500

12,757

37,550

30,007

20,168

12,702

25,185

13,540

6,341

16,812

16,781

45,351

9,843

16,635

10,822

1,280

2,915

32,560

20,366

7,987

Deferred income tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

210

210

210

210

1,161

1,161

1,161

1,161

3,139

3,139

3,139

3,139

19,974

-

-

1,014

-

-

-

-

-

-

-

Prepaid expenses and other current assets

3,653

2,912

2,329

3,289

3,686

3,125

3,121

3,509

3,801

2,938

3,520

4,116

5,138

3,245

3,773

4,310

4,352

4,219

4,926

5,146

5,057

4,355

5,794

5,790

7,617

7,546

7,414

8,455

5,101

2,427

3,045

1,786

2,431

803

927

1,939

1,679

Total current assets

162,385

171,765

173,459

183,500

195,522

201,472

157,103

143,982

188,203

139,695

162,388

136,633

169,682

188,490

218,066

194,896

186,589

183,877

187,340

210,749

201,780

218,708

248,351

254,952

253,289

273,728

329,501

345,361

377,900

324,563

430,478

441,970

453,394

325,048

350,664

321,720

112,181

Long-term restricted cash

35,000

35,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment at fair value (Note 5)

1,387

1,500

2,674

9,070

-

7,459

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments at fair value

-

-

-

-

5,483

-

36,648

75,004

63,657

104,754

208,796

49,817

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investments (Note 6)

-

-

0

0

8,195

8,195

8,195

8,195

8,195

2,195

2,284

2,400

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patents, net of accumulated amortization

12,550

7,814

8,671

9,534

-

6,587

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Leased right-of-use assets

1,395

1,264

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan receivable and accrued interest

-

-

-

-

-

-

-

-

-

-

0

0

19,749

18,616

8,474

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment warrants

-

-

-

-

-

-

-

-

-

-

0

0

2,196

1,960

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment at cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,720

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net of accumulated depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

94

-

155

189

231

272

319

374

421

500

634

701

782

766

778

607

536

339

317

342

212

220

232

177

135

Patents, net

-

-

-

-

9,681

-

18,147

23,099

56,587

61,917

67,360

75,233

80,804

86,319

94,716

100,958

151,882

162,642

249,486

262,337

274,659

286,636

269,435

282,524

290,197

288,432

296,272

303,489

305,809

313,529

226,317

214,204

171,262

25,188

14,665

15,836

19,803

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,149

30,149

30,149

30,149

30,149

30,149

30,149

30,149

30,149

30,149

30,149

30,149

36,217

36,217

36,202

0

-

-

-

Investments - noncurrent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,506

1,956

1,956

1,956

1,975

2,001

Other non-current assets

1,004

818

2,126

1,658

216

236

183

187

1,193

207

382

407

336

618

365

365

1,111

1,110

353

355

355

355

351

350

309

318

1,016

986

138

137

417

462

465

465

467

467

664

Total assets

213,721

218,161

186,930

203,762

219,097

223,949

220,276

250,467

317,835

308,768

441,210

264,490

272,861

296,003

323,496

296,408

339,813

347,901

467,647

503,964

507,364

536,348

548,920

568,676

574,726

593,393

657,716

680,592

714,532

668,717

693,746

694,701

663,491

352,877

367,984

340,175

134,784

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

3,136

1,765

-

-

-

3,698

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

4,376

7,265

8,268

9,461

11,448

4,299

9,067

8,855

9,040

7,956

7,691

9,239

11,712

14,283

22,688

11,424

14,580

17,347

17,477

11,525

12,705

14,860

16,564

16,788

12,295

11,555

16,310

15,592

17,127

9,235

16,388

18,648

8,407

6,625

7,201

7,645

7,099

Accrued compensation

1,127

507

-

-

-

350

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued Patent Acquisition Related Payments, Current

-

-

-

-

3,750

-

-

-

-

-

-

-

-

-

225

0

0

1,000

0

0

900

16,700

4,000

6,000

19,250

4,000

8,750

6,508

-

250

-

-

-

-

-

-

-

Royalties and contingent legal fees payable

2,070

2,178

2,274

10,518

16,149

22,688

7,193

4,765

39,937

1,601

19,824

9,427

3,078

13,908

25,009

17,854

18,618

14,878

9,243

20,181

19,129

14,351

17,777

20,312

3,895

10,447

8,313

19,986

36,736

12,508

21,478

19,103

14,095

23,508

37,050

22,691

12,760

Other current liabilities

-

-

29

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

10,709

11,715

10,571

20,014

31,347

31,035

16,260

13,620

48,977

9,557

27,515

18,666

14,790

28,191

47,922

29,278

33,198

33,225

26,720

31,706

32,734

45,911

38,341

43,100

35,440

26,002

33,373

42,086

53,863

21,993

37,866

37,751

22,502

30,133

44,251

30,336

19,859

Series A warrant liabilities

2,610

3,568

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A embedded derivative liabilities

21,682

17,974

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B warrant liabilities

6,231

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term lease liabilities

1,395

1,264

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

210

210

210

210

1,161

1,161

1,161

1,161

3,343

3,206

3,747

4,874

17,748

17,279

27,831

27,831

33,616

32,592

32,363

0

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

3,552

-

-

-

369

-

-

-

311

-

-

-

228

-

-

-

319

-

-

-

415

-

-

-

632

-

-

-

Other long-term liabilities

583

593

2,050

2,131

916

1,674

1,874

2,471

1,805

-

8,752

577

380

-

362

354

345

-

291

271

250

-

310

319

319

-

1,322

2,323

494

-

659

654

642

-

608

629

1,072

Total liabilities

43,210

35,114

12,621

22,145

32,263

32,709

18,134

16,091

50,782

13,109

36,267

19,243

15,170

28,560

48,494

29,842

33,753

33,746

28,172

33,138

34,145

47,300

41,994

46,625

39,506

31,195

52,443

61,688

82,188

50,239

72,141

70,997

55,507

30,765

44,859

30,965

20,931

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of March 31, 2020 and December 31, 2019, respectively; aggregate liquidation preference of $35,000 as of March 31, 2020 and December 31, 2019, respectively

8,720

8,089

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,813,443 and 50,370,987 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

50

50

50

50

50

50

50

49

51

51

51

51

51

50

50

50

50

51

51

51

51

50

50

50

50

49

50

50

49

49

50

50

50

43

43

43

36

Treasury stock, at cost, 3,496,726 and 2,919,828 shares as of March 31, 2020 and December 31, 2019, respectively

40,586

39,272

39,272

39,272

39,272

39,272

39,272

39,272

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

34,640

26,731

26,731

26,731

26,731

-

-

-

0

-

-

-

Additional paid-in capital

651,441

652,003

651,988

651,688

651,148

651,156

650,814

650,265

649,724

648,996

647,930

646,627

644,794

642,453

639,118

636,332

634,882

633,146

637,029

641,207

644,404

646,595

648,760

651,053

650,934

653,314

653,326

651,346

650,966

644,982

631,000

627,825

618,683

386,821

384,283

379,001

197,026

Accumulated comprehensive loss

-

-

-

-

-

-

-

-

-

-88

-

-

-

-76

-

-

-

-215

-

-

-

-353

-

-

-

-947

-

-

-

-1,166

-

-

-

-1,830

-

-

-

Accumulated comprehensive loss

-

-

-

-

-

-

-122

-202

-125

-

-38

-62

-49

-

-59

-171

-148

-

-233

-413

-440

-

-781

-784

-976

-

-783

-658

-317

-

382

797

600

-

-1,913

-

0

Accumulated deficit

-450,947

-439,656

-440,290

-432,682

-426,925

-422,541

-411,172

-377,977

-349,550

-320,018

-209,815

-368,280

-354,028

-342,198

-331,587

-338,669

-298,096

-288,131

-172,221

-144,911

-141,225

-128,095

-111,851

-99,436

-86,487

-62,066

-28,733

-13,022

-519

-5,632

-15,455

-8,836

-15,157

-65,085

-60,896

-71,699

-86,191

Total Acacia Research Corporation stockholders' equity

159,958

173,125

172,476

179,784

185,001

189,393

200,298

232,863

265,460

294,301

403,488

243,696

256,128

265,589

272,882

262,902

302,048

310,211

429,986

461,294

468,150

483,557

501,538

516,243

528,881

555,710

597,129

610,985

623,448

611,502

615,977

619,836

604,176

319,949

321,517

307,345

110,871

Noncontrolling interests

1,833

1,833

1,833

1,833

1,833

1,847

1,844

1,513

1,593

1,358

1,455

1,551

1,563

1,854

2,120

3,664

4,012

3,944

9,489

9,532

5,069

5,491

5,388

5,808

6,339

6,488

8,144

7,919

8,896

6,976

5,628

3,868

3,808

2,163

1,608

1,865

2,982

Total stockholders' equity

161,791

174,958

174,309

181,617

186,834

191,240

202,142

234,376

267,053

295,659

404,943

245,247

257,691

267,443

275,002

266,566

306,060

314,155

439,475

470,826

473,219

489,048

506,926

522,051

535,220

562,198

605,273

618,904

632,344

618,478

621,605

623,704

607,984

322,112

323,125

309,210

113,853

Total liabilities, redeemable convertible preferred stock, and stockholders' equity

213,721

218,161

186,930

203,762

219,097

223,949

220,276

250,467

317,835

308,768

441,210

264,490

272,861

296,003

323,496

296,408

339,813

347,901

467,647

503,964

507,364

536,348

548,920

568,676

574,726

593,393

657,716

680,592

714,532

668,717

693,746

694,701

663,491

352,877

367,984

340,175

134,784